Episodios

  • Episode Seven: Family Reach with CEO Carla Tardif and Iron Chef Ming Tsai

    Episode Seven: Family Reach with CEO Carla Tardif and Iron Chef Ming Tsai
    Jul 15 2024
    On this week’s episode, our 7th, of Get Real With The Chairman, were honored to speak with Carla Tardif, CEO of Family Reach and Iron Chef Ming Tsai, founder of MingsBings, TV host, restaurateur, and active board member at Family Reach.. Family Reach a non profit that provides financial assistance to families facing cancer by covering costs such as rent, mortgage, utilities, and transportation. They’re committed to building a healthcare system where no family has to choose between health and home. Carla is a two-time breast cancer survivor, and member of the White House Cancer Moonshot. Under her leadership, Family Reach has grown its network from five east coast hospital partnerships to more than 1,000 top-tier partnerships nationwide. She is committed to building a healthcare system where no family facing cancer has to choose between rent, copays, medication or groceries. Iron Chef Ming Tsai has raised over $11 million for the organization to date and is the host of their signature event, Cooking Live. He uses his national platform to promote the healing power of food. In the US, 1 in 3 families can’t afford their basic needs during cancer treatment. Family Reach is here to help. They’re looking for partnerships, too. We’re honored to share their impactful work. Please tune into this meaningful episode and visit their website to learn more.
    Más Menos
    31 m
  • Episode Six: Kathy Guisti (CEO of The MMRF and Author of Fatal to Fearless: 12 Steps to Beating Cancer in a Broken Medical System)

    Episode Six: Kathy Guisti (CEO of The MMRF and Author of Fatal to Fearless: 12 Steps to Beating Cancer in a Broken Medical System)
    Jul 8 2024
    Our guest for our sixth episode is the formidable Kathy Giusti, Co-Founder and CEO of The Multiple Myeloma Research Foundation, also known as The MMRF. In this conversation, we’re discussing her debut book, “Fatal to Fearless: 12 Steps to Beating Cancer in a Broken Medical System.” Kathy has been in remission from Multiple Myeloma, a devastating blood cancer affecting the plasma cells in bone marrow, for nearly three decades. In 1998, she co-founded The Multiple Myeloma Research Foundation, a nonprofit accelerating the development of innovative treatments for this cancer. The MMRF single-handedly changed the paradigm for those diagnosed with Multiple Myeloma. As of today, they’ve raised half a billion dollars for the disease. Fatal to Fearless is a tour de force guide to approaching a cancer diagnosis with tools, takeaways, and anecdotes.Please purchase her book for yourself and for anyone you know who has been impacted by cancer, which statistically speaking is one in every two people…that’s all of us! And don’t forget to rate it, too! It’s an honor to have her as our next guest on Get Real with the Chairman. Purchase her book here: https://www.amazon.com/Fatal-Fearless-Beating-Cancer-Medical/dp/0063282178
    Más Menos
    35 m
  • Episode Five: Dr. Laura Esserman and Dr. Steve Birrell (Pioneering Androgen Therapies for Breast Cancer & Should All Breast Cancers Be Called Cancer?)

    Episode Five: Dr. Laura Esserman and Dr. Steve Birrell (Pioneering Androgen Therapies for Breast Cancer & Should All Breast Cancers Be Called Cancer?)
    Jun 5 2024
    In this episode, you'll meet Dr. Laura Esserman and Dr. Steve Birrell, who are collaborating to change the breast cancer treatment paradigm. This topic is more relevant than ever, given recent developments in the world of celebrities and influencers, such as Olivia Munn, who announced she had a double mastectomy for Luminal B breast cancer. Dr. Esserman is a force of nature in breast cancer. Since 1993, she’s worked at UCSF as a surgeon and oncology specialist, and co-lead of their Breast Oncology Program. She’s gained an audience by publishing over 400 peer-reviewed articles and appearing in mainstream news, such as the New York Times, where she published a provocative editorial this summer on whether Ductal Carcinoma in SITU should still be called cancer. In 2016, she was named one of TIME magazine’s 100 Most Influential. She was also a member of President Obama’s Council of Advisors on Science and Technology. Dr. Esserman is the Principal Investigator of the I-SPY TRIAL group with the incomparable Dr. Steve Birrell, Founder of HAVAH Therapeutics, based in Adelaide, Australia. Havah is developing a potentially revolutionary testosterone-based approach to the treatment of breast cancer. Dr. Birrell’s three-decade career in cancer spans many roles. He’s a specialist, surgeon, medical innovator, and one of the most published molecular oncologists. The two of them are collaborating on an I-SPY trial reevaluating the treatment of DCIS. Tune in as we’ll talk about the context and rationale for this trial and the science as we learn about them and how their passions outside of their research fuel their commitment to innovation.
    Más Menos
    45 m
  • Episode Four: Mary Stutts (CEO of the Healthcare Businesswomen's Association)

    Episode Four: Mary Stutts (CEO of the Healthcare Businesswomen's Association)
    May 6 2024
    Mary Stutts is the CEO of the Healthcare Businesswomen's Association, also known as HBA. HBA is a global nonprofit dedicated to advancing women's impact and involvement in the healthcare industries at large. Mary has had an extensive and diverse career in healthcare. She’s worked in leadership positions at Genentech, Bayer, Bristol Myers Squibb, Sumitovant, UnitedHealth Group, Kaiser Permanente, Stanford Health Care, and Comcast NBC-Universal. Before joining HBA, she served as Chief Global Health Equity and Inclusion Officer for our company, Real Chemistry. Mary is a perfect match for her role as CEO of HBA. HBA provides a platform for women in healthcare to elevate their careers through developing diverse professional networks. They are laser-focused on community growth with myriad opportunities for women to connect and support each other in their careers. They also have a robust professional development arm with programs, events, and resources for women in health, including mentorship, leadership development, advocacy, and skill-building workshops.
    Más Menos
    25 m
  • Episode Three: Dr. Karen Knudsen (CEO of the American Cancer Society)

    Episode Three: Dr. Karen Knudsen (CEO of the American Cancer Society)
    Apr 15 2024
    Dr. Karen Knudsen currently serves as the CEO of the American Cancer Society and the American Cancer Society Cancer Action Network. She’s also an internationally recognized oncology leader, guided by the goal of improving the lives of cancer patients and their families. She served as tenured faculty at the University of Cincinnati College of Medicine prior to recruitment to Thomas Jefferson University in 2007. Before her role as the CEO at ACS, she was the Executive Vice President of Oncology Services for Jefferson Health and Director of the Sidney Kimmel Cancer Center, one of the elite National Cancer Institute’s NCI-Designated Cancer Centers in the US. Dr. Knudsen is well-known for her discoveries in prostate cancer, advancing our understanding of the molecular and cellular mechanisms underlying this common diagnosis and paving the way for targeted therapies. She’s also known for her advocacy work, emphasizing cancer prevention, early detection, research funding, and new treatments. In addition to being CEO of the American Cancer Society, she serves on the board of advisors for the National Cancer Institute and on twelve external advisory boards for NCI-Designated Cancer Centers.
    Más Menos
    36 m
  • Episode Two: Dr. Reed Tuckson (Managing Director, Tuckson Health Connections)

    Episode Two: Dr. Reed Tuckson (Managing Director, Tuckson Health Connections)
    Apr 1 2024
    Dr. Reed Tuckson's career includes pivotal roles as the Commissioner of Public Health for the District of Columbia during the HIV/AIDS crisis and as the Executive Vice President and Chief of Medical Affairs for UnitedHealth Group. His advocacy has been instrumental in addressing disparities and advocating for equitable healthcare access. He serves as a committee member of the Coalition for Trust in Health and Science, a nonpartisan nonprofit dedicated to fostering trust in healthcare and scientific endeavors. He is also the Managing Director of Tuckson Health Connections, where he is pioneering data-driven solutions to shift healthcare delivery, enhance patient outcomes, and streamline systems. His dedication to public health serves as a guiding light in striving toward a healthier future for all. As a graduate of Howard University, he is on the board of visitors for the College of Arts and Sciences to pave new pathways for future liberal arts students. In this episode, he and Jim address critical issues such as championing individuals with sickle cell disease and advocating for improved healthcare in Black communities. Reed is concerned with increasing American trust in healthcare and decreasing tribalism, which keeps Americans apart, not together. When he's not changing healthcare, Reed is also a sage, so be prepared to learn about the writers and poets he reads daily, Rumi included.
    Más Menos
    32 m
  • Episode One: Sung Poblete (CEO of FARE)

    Episode One: Sung Poblete (CEO of FARE)
    Mar 18 2024
    Sung Poblete serves as the CEO of FARE, an acronym for Food Allergy Research and Education. FARE is a non-profit dedicated to funding research, advancing treatment options, and raising awareness about the serious public health impact of food allergies. In this episode, you'll learn why food allergies affect over 30 million Americans and why they haven't received the attention they deserve as a tier-one health issue. Our aim is to support FARE in changing this reality. Despite being the largest food allergy-focused organization in the United States, FARE is relatively young at just 11 years old and relies on support from donors, sponsors, and allies to expand its efforts. In this episode, Sung and Jim discuss the genetic origins of allergies and how they manifest, as well as the continued reliance on EpiPens as the primary treatment for anaphylaxis despite the rising prevalence of life-threatening food allergies, affecting approximately 1 in 13 children. The cost of EpiPens, around $1400 per year, poses a significant financial burden for the 44 million Americans who require them. Poblete emphasizes the need to make giving to FARE's cause appealing and stresses the importance of funding for discovery and translational research to provide treatment options while scientists work towards a cure. As a Real Health Citizen, her insights are invaluable, and we're honored to have her on Get Real with the Chairman.
    Más Menos
    37 m
  • Trailer

    Trailer
    Mar 11 2024
    Tune in bi-weekly on Mondays to hear Jim's conversations with some of the most prominent movers and shakers in healthcare. Jim won't shy away from what's working and what's not. He'll steer listeners toward deeper questions in his segment called "So What's It All Mean?" where he asks his guests how the topics and themes in their conversation are playing out in the world. He'll also get personal. As Jim says, "Everyone will get hit by the bouncing ball." Health is universal.
    Más Menos
    2 m